{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:38:55Z","timestamp":1719952735658},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.06.018","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T20:35:31Z","timestamp":1529354131000},"page":"425-431","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of co-administration of two different phosphodiesterase inhibitors and a \u03b23-adrenoceptor agonist in an experimental model of detrusor overactivity"],"prefix":"10.1016","volume":"833","author":[{"given":"Bruno Lima","family":"Linhares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilberto Robson Falc\u00e3o","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facio Fl\u00e1vio","family":"Gonzaga-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Ferreira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel Odorico","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Bernardo","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Patr\u00edcia Gon\u00e7alves","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manass\u00e9s Claudino","family":"Fonteles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Reges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.06.018_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/TCRM.S33052","article-title":"New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA","volume":"9","author":"Andersson","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2018.06.018_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.juro.2013.02.104","article-title":"Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder","volume":"190","author":"Andersson","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s11255-017-1671-2","article-title":"Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast","volume":"49","author":"Ding","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/01.ju.0000054885.51858.99","article-title":"Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction","volume":"169","author":"Felsen","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib8","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/S0022-5347(05)64245-0","article-title":"Activity and expression of nitric oxide synthase in the hypertrophied rat bladder and the effect of nitric oxide on bladder smooth muscle growth","volume":"168","author":"Johansson","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-5347(05)64634-4","article-title":"Effects of selective beta2 and beta3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats","volume":"168","author":"Kaidoh","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1464-410X.2007.07307.x","article-title":"The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction","volume":"101","author":"Kaiho","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2018.06.018_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2490-13-45","article-title":"Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial","volume":"13","author":"Khullar","year":"2013","journal-title":"BMC Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.bjp.0701328","article-title":"The role of cyclic nucleotides in guinea-pig bladder contractility","volume":"121","author":"Longhurst","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib13","series-title":"Campbell-Walsh Urology","first-page":"688","article-title":"Phisiology of penile erection and pathophysiology of erectile dysfunction","author":"Lue","year":"2012"},{"key":"10.1016\/j.ejphar.2018.06.018_bib14","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0022-5347(05)65135-X","article-title":"Localization and role of nitric oxide synthase and endogenous nitirc oxide synthase inhibitors in the rabbit lower urinary tract","volume":"167","author":"Masuda","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","article-title":"Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"174","author":"Mcvary","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2005.09.037","article-title":"Mesenteritis precedes vasculitis in the rat mesentery after subacute","author":"Meckelenburg","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2018.06.018_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/bjp.2008.39","article-title":"Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity","volume":"153","author":"Monica","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1743-6109.2009.01249.x","article-title":"Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA\/Rho kinase signaling pathway in spontaneously hypertensive rats","volume":"6","author":"Morelli","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejphar.2018.06.018_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000282424","article-title":"Regional difference in functional roles of cAMP and cGMP in lower urinary tract smooth muscle contractility","volume":"49","author":"Morita","year":"1992","journal-title":"Urol. Int."},{"key":"10.1016\/j.ejphar.2018.06.018_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1464-410X.2006.06643.x","article-title":"Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor","volume":"99","author":"Nishiguchi","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2018.06.018_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2006.10.023","article-title":"Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition","volume":"51","author":"Oger","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/S1677-5538.IBJU.2013.02.16","article-title":"Effect of acute administration of sildenafil to rats with detrusor overactivity induced by chronic deficiency of nitric oxide","volume":"39","author":"Reges","year":"2013","journal-title":"Int. Braz. J. Urol."},{"issue":"3","key":"10.1016\/j.ejphar.2018.06.018_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5410\/wjcu.v3.i3.249","article-title":"Phosphodiesterase inhibitors for treatment of voiding dysfunction: an overview of experimental and clinical evidence","volume":"3","author":"Reges","year":"2014","journal-title":"World J. Clin. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00304074","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle: I. Identification and characterization","volume":"24","author":"Truss","year":"1996","journal-title":"Urol. Res."},{"key":"10.1016\/j.ejphar.2018.06.018_bib25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2006.05.025","article-title":"Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future","volume":"50","author":"Uckert","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjp.0704470","article-title":"The role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscle","volume":"135","author":"Yamanishi","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.018_bib27","series-title":"Campbell-Walsh Urology","first-page":"1786","article-title":"Phisiology and Pharmacology of the bladder and urethra","author":"Yoshimura","year":"2012"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T12:17:18Z","timestamp":1538396238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"alternative-id":["S0014299918303509"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of co-administration of two different phosphodiesterase inhibitors and a \u03b23-adrenoceptor agonist in an experimental model of detrusor overactivity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}